Chemoinformaics analysis of Des-Rhamnosylverbascoside
| Molecular Weight | 478.45 | nRot | 8 |
| Heavy Atom Molecular Weight | 452.242 | nRig | 20 |
| Exact Molecular Weight | 478.148 | nRing | 3 |
| Solubility: LogS | -1.672 | nHRing | 1 |
| Solubility: LogP | 1.117 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 2 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 12 |
| nHA | 11 | APOL | 64.5686 |
| nHD | 7 | BPOL | 32.1594 |
| QED | 0.155 |
| Synth | 3.956 |
| Natural Product Likeliness | 1.797 |
| NR-PPAR-gamma | 0.729 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.915 |
| HIA | 0.938 |
| CACO-2 | -6.338 |
| MDCK | 0.0000083 |
| BBB | 0.04 |
| PPB | 0.958914 |
| VDSS | 0.52 |
| FU | 0.0503445 |
| CYP1A2-inh | 0.258 |
| CYP1A2-sub | 0.027 |
| CYP2c19-inh | 0.119 |
| CYP2c19-sub | 0.053 |
| CYP2c9-inh | 0.309 |
| CYP2c9-sub | 0.344 |
| CYP2d6-inh | 0.188 |
| CYP2d6-sub | 0.187 |
| CYP3a4-inh | 0.09 |
| CYP3a4-sub | 0.068 |
| CL | 11.282 |
| T12 | 0.915 |
| hERG | 0.076 |
| Ames | 0.731 |
| ROA | 0.152 |
| SkinSen | 0.968 |
| Carcinogencity | 0.051 |
| EI | 0.214 |
| Respiratory | 0.026 |
| NR-Aromatase | 0.833 |
| Antiviral | Yes |
| Prediction | 0.788845 |